ReviewNewborn screening for cystic fibrosis: Its evolution and a review of the current situation
References (103)
- et al.
Hypoalbuminaemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening
J Pediatr
(1985) - et al.
Early bacteriologic, immunologic, and clinical course of young infants with cystic fibrosis identified by neonatal screening
J Pediatr
(1991) - et al.
Two-tier screen for cystic fibrosis
Lancet
(1981) - et al.
Newborn screening for cystic fibrosis using an enzyme linked immunosorbent assay (ELISA) technique
Clin Chim Acta
(1988) - et al.
A monoclonal antibodybased trypsinogen EIA for screening of neonates for cystic fibrosis
Lancet
(1987) - et al.
Cystic fibrosis screening in the newborn
Lancet
(1977) - et al.
Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots
Clin Chim Acta
(1981) - et al.
Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening
J Pediatr
(1989) - et al.
Neonatal screening for cystic fibrosis
Adv Pediatr
(1992) - et al.
Immunoreactive pancreatic lipase test for neonatal detection of cystic fibrosis
Lancet
(1984)
Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin
Lancet
Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance cel
Sensitive trypsin assay for dried blood specimens as a screening procedure for early detection of cystic fibrosis
Lancet
Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention
Am J Clin Nutr
Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by newborn screening
J Pediatr
Hypoalbuminaemia at initial examination in patients with cystic fibrosis
J Pediatr
Fat-soluble vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns
Am J Clin Nutr
Reduced morbidity in cystic fibrosis
Lancet
Cystic fibrosis screening by dried blood spot trypsin assay: results in 75000 newborn infants
J Pediatr
Reduced morbidity in patients with cystic fibrosis detected by neonatal screening
Lancet
Early respiratory course in infants with cystic fibrosis
Pediatr Pulmonol
Neonatal screening for cystic fibrosis: Position paper
Pediatr
Serum pancreatic lipase as a screening test for cystic fibrosis
Arch Dis Childh
Attitudes of parents of cystic fibrosis ch:.ldren towards neonatal screening and antenatal diagnosis
Clin Genet
Cystic fibrosis of the panceas and its relation to coeliac disease
Am J Dis Child
Generation of cAMP-activated chloride currents by expression of CFTR
Science
Dried blood spot screening for cystic fibrosis
Lancet
Neonatal screening for cystic fibrosis
Monogr Paediatr
Effects of newborn screening of cystic fibrosis on reported maternal behaviour
Arch Dis Child
Neonatal screening for cystic fibrosis
Arch Dis Child
Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis
J. Pediatr.
Variations in dried blood spot immunoreactive trypsin in relation to gestational age and during the first week of life
Eur J Pediatr
Neonatal screening for cystic fibrosis by dried blood spot trypsin assay: results in 47127 newborn infants from a homogenous population
Acta Paediatr Scand
Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening
Arch Dis Child
Dried blood spot screening for cystic fibrosis in the newborn
Lancet
The Cystic Fibrosis Genetic Analysis Consortium. Worldwide survey of the F508 mutation
Am J Hum. Genet
Effect of screening for cystic fibrosis on genetic counselling
Clin Genet
Cystic fibrosis: early detection and clinical course
A cost analysis of blood-spot screening newborns for cystic fibrosis
J Clin Immunoassay
Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Clinical significance and relationship to the disease
Pediatrics
Screening for cystic fibrosis
Arch Dis Child
Immunoreactive trypsin on dried blood spots as a possible neonatal test for cystic fibrosis
La Ricerca Clin Lab
Early diagnosis of cystic fibrosis: to screen or not to screen - an important question
Pediatrics
Current issues in neonatal screening for cystic fibrosis
Pediatr Pulmonol
Neonatal screening for cystic fibrosis: clinical features, evaluation of testing procedures, and randomised investigation of benefits and risks
Screening for cystic fibrosis by a stool trypsin method
Arch Dis Child
Diagnosis of cystic fibrosis: results of screening vs no screening in a three year programme
CF Club Abstracts
Assessment of pancreatic function in screened infants with cystic fibrosis
Pediatr Pulmonol
Screening of newborns for cystic fibrosis
Am J Dis Child
A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis
Pediatrics
Cited by (48)
Nutrition and Cystic Fibrosis
2013, Nutrition in the Prevention and Treatment of DiseaseNutrition and Cystic Fibrosis
2012, Nutrition in the Prevention and Treatment of Disease, Third EditionEuropean best practice guidelines for cystic fibrosis neonatal screening
2009, Journal of Cystic FibrosisCitation Excerpt :This is to minimise effects of volumetric variability of the punched discs, day-to-day variation in IRT assay calibration, and to detect contamination of the sample with faeces or possibly sample misidentification. There are significant differences among commercially available IRT assay kits in terms of the value assigned to the initial cut-off and possibly also in the rate of decline of measured IRT in positive cases during the first few weeks of life [57,58]. Despite such variability, all the current commercial IRT assays seem to produce satisfactory results.
Newborn screening for cystic fibrosis offers an advantage over symptomatic diagnosis for the long term benefit of patients: the motion for
2008, Paediatric Respiratory ReviewsCitation Excerpt :A chromatographic strip test to measure meconium albumin was later widely used,12 but had a high rate of both false-positive and false-negative results. Only when Crossley and colleagues1 published a dried blood spot method of measuring immunoreactive trypsinogen (IRT) (which is elevated in neonates with CF) did NBS really become a possibility, and prospective studies were carried out in several parts of the world.13 The IRT test has poor specificity in the first days of life, and protocols involved a second test for babies with an elevated IRT, followed by a sweat test for those whose second test result remained elevated.
From the laboratory to the clinic: Neonatal screening for cystic fibrosis
2005, Anales de Pediatria ContinuadaNewborn Screening
2005, Avery's Diseases of the Newborn